This inventor holds 3 USPTO granted patents. Top assignees: Progenics Pharmaceuticals, Inc., Aaron Diamond Aids Research Centre, Albert Einstein College of Medicine. Active years: 2003-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 71 
1 out of 1 
1 out of 514 
Years Active: 2003-2008
Title: Tatjana Dragic: Innovator in Viral Research
Introduction
Tatjana Dragic is a notable inventor based in Scarsdale, NY (US). She has made significant contributions to the field of viral research, particularly in the development of therapies targeting hepatitis C and HIV-1 infections. With a total of 3 patents, her work has the potential to impact public health significantly.
Latest Patents
Tatjana's latest patents include groundbreaking inventions. One of her patents focuses on sequences encoding hepatitis C virus glycoproteins. This invention concerns a modified nucleic acid molecule that includes a nucleotide sequence coding for full-length hepatitis C virus (HCV) glycoproteins. The invention aims to eliminate specific RNA splice sites, enhancing the expression of HCV glycoproteins on cell surfaces and pseudovirions. Additionally, it provides methods for determining agents that inhibit HCV fusion and entry into target cells, along with treatments for HCV-associated disorders.
Another significant patent involves sulfated CCR5 peptides for HIV-1 infection. This invention presents a compound with a specific amino acid structure designed to inhibit HIV-1 infection. The compound includes sulfated tyrosines, which are crucial for its function, and offers a novel approach to combatting HIV-1.
Career Highlights
Throughout her career, Tatjana has worked with Progenics Pharmaceuticals, Inc., where she contributed to innovative research in viral therapies. Her expertise in molecular biology and virology has positioned her as a key figure in her field.
Collaborations
Tatjana has collaborated with notable professionals, including William C. Olson and Julie Dumonceaux. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.
Conclusion
Tatjana Dragic's contributions to viral research through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for advancements in the treatment of viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile